期刊文献+

猪血红蛋白及戊二醛聚合猪血红蛋白氧载体的研究 被引量:6

A study on porcine hemoglobin and glutaraldehyde-polymerized porcine hemoglobin as hemoglobin-based oxygen carriers
下载PDF
导出
摘要 目的阐明猪血红蛋白的主要理化特性,并了解戊二醛聚合反应对猪血红蛋白主要性能的影响。方法猪血经多步纯化获取高纯度猪血红蛋白,以戊二醛为交联剂制备聚合猪血红蛋白样品。鉴定猪血红蛋白的纯度、聚合体分子量分布、携氧性能及自氧化等指标。结果猪血红蛋白在生理pH条件下的P50为23.6 mmHg,Hill系数为2.86。聚合猪血红蛋白为分子量大小不均一的混合体,聚合体P50和Hill系数均减小,自氧化趋势增大。结论猪血红蛋白具有较高氧亲和力,与人血红蛋白相似,明显高于牛血红蛋白。猪血红蛋白的丰富来源、特殊的氧亲和力和较好的化学稳定性等特点使其可成为一种血红蛋白类氧载体产品制备的有用材料。 Aim This study was to demonstrate the major physical and chemical properties of porcine hemoglobin (pHb) and polymerized porcine hemoglobin. Methods Ultra-pure pHb was obtained through multiple purification steps; with glutaraldehyde as the cross-linker, pPolyHb was then produced; purity of the purified pHb, molecular weight distribution of pPolyHb, oxygen affinity and auto-oxidation of Hb were analyzed. Results At a physiologi- cal pH condition, pHb had a P50 about 23.6 mmHg and Hill coefficient about 2.86. pPolyHb was composed of Hb polymers of various molecular sizes with increased oxygen affinity and decreased Hill coefficient. The polymerization increased the tendency of auto-oxidation of the products. Conclusion pHb has high oxygen affinity, similar to that of human Hb and much higher than that of bovineHb. Rich supply, the unique properties of P50 of pHb could make it a useful material in hemoglobin-based oxygen carriers(HBOCs).
出处 《西北大学学报(自然科学版)》 CAS CSCD 北大核心 2008年第4期613-616,共4页 Journal of Northwest University(Natural Science Edition)
基金 国家"863计划"基金资助项目(2004AA205030)
关键词 猪血红蛋白 氧亲和力 戊二醛聚合猪血红蛋白 血红蛋白氧载体 porcine hemoglobin oxygen affinity glutaraldehyde-polymerized porcine hemoglobin HBOCs
  • 相关文献

参考文献9

  • 1KEVIN K, ANBAKI J P, GARINO C F. Hemoglobin substitutes [ J ]. Eur Spine J ,2004,13 ( 1 ) :76-82.
  • 2MARK T G, RAKESH P. Serial review:Biomedical implications for hemoglobin interactions with nitric oxide [ J ]. Free Radical Biology and Medicine, 2004,36 ( 6 ) : 685- 697.
  • 3THOMAS M S C. Hemoglobin-based red blood cell substitutes [ J ]. Artificial Organs ,2004,28 (9) :789-794.
  • 4HAE W K, GERSON G. Artificial oxygen carriers as red blood cell substitutes: A selected review and current stares[J]. Artificial Organs 2004, 28(9) :813-828.
  • 5NARIN S K,STEVEN P W,WEN H. Structure determination of aquomet porcine hemoglobin at 2. 8 a resolution [J].J Mol Biol,1994,244:541-553.
  • 6HARRIS E L V. Protein purification methods, a practical approach [ J ]. Oxford University Press, 1989:34-35.
  • 7CLARA F,EMRZCO B,CHAKLES O. Solvent regulation of oxygen affinity in hemoglobin [ J ]. The Journal of Biological Chemistry, 1984, 259 (17) : 10 841-10 844.
  • 8WINSLOW R M. Current status of blood substitute research: towards a new paradigm[J]. J Intern Med,2003, 253: 508- 517.
  • 9JULIE H, ANDRE F P. Effect of glutaraldehyde concentration on the physical properties of pelymerized hemoglobin based oxygen carriers [ J ]. Biotechnol Prog,2004, 20: 1 225-1 232.

同被引文献62

  • 1李军,吴梧桐.高活性高纯度猪血红蛋白的制备与性质研究[J].中国天然药物,2005,3(1):60-64. 被引量:9
  • 2李涛,张鸿辉,王红,余蓉,杨成民.人脐带血血红蛋白的分离纯化与病毒灭活研究[J].生物医学工程学杂志,2006,23(3):640-644. 被引量:8
  • 3薛树仁.血红蛋白氧载体在血运重建前对缺血心肌保护的应用前景[J].中华内科杂志,2006,45(9):779-780. 被引量:2
  • 4田荟琳,张坤生.猪血中过氧化氢酶提取及其性质研究[J].食品科学,2006,27(12):311-314. 被引量:14
  • 5SPAHN D R, KOCIAN R. Artificial O2 carriers: status in [J]. Curr Pharm Des,2005,11 (31) :4 099-4 114.
  • 6HUGHES GS JR, YANCEY E P, ALBRECHT R, et al. Hemoglobin-based oxygen cartier preserves submaximal exercise capacity in humans[J]. Clin Pharmacol Ther, 1995,58(4) :434-443.
  • 7World Anti-doping Agency. The 2006 Prohibited List Internationl Standard[EB/OL]. 19 Septemev 2005. http: ff www. wada-ama. org/rtecontent/document/2006_ LIST.pdf.
  • 8GOEBEL C, ALMA C, OWE H, et al. Methodologies for detection of hemoylobin-basod onygen carriers [J]. J Chromatogr Sci,2005,43( 1 ) :39-46.
  • 9LASNE F, CREPIN N, ASHENDEN M, et al. Detection of hemoglobin-based oxygen carries in human serum for poping analysis: screening by electrophoresis [ J ]. Clinical Chemistry,2004,50(2) :410-415.
  • 10THEVIS M, OGOBZALEK LOO RR, LOO J A, et al. Doping control analysis of bovine hemoglobin-based onygen therapeutics in human plasma by LC-electrosprayioniza- tion-MS/MS[ J]. Anal Chem,2003,75 (14) :87-93.

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部